MT-ND5 and cancer: Forced overexpression of mutant forms of MT-ND5 or MT-ND2 with missense mutations in cancer cells carrying wild type mtDNA increases ROSproduction, confers a growth advantage and stimulates aerobic glycolysis through hypoxia-inducible factor 1α (HIF1α) [30,31,32].